A Phase 3 Multicenter, Randomized Study of Rucaparib versus Chemotherapy in Patients with Relapsed, BRCA-Mutant, High-Grade Epithelial Ovarian, Fillopian Tube, or Primary Peritoneal Cancer, NCT02855944
PURPOSE OF THIS CLINICAL RESEARCH TRIAL
The purpose of this study is to determine how patients with ovarian, fallopian tube, and primary peritoneal cancer will best respond to treatment with rucaparib versus chemotherapy.
MORE DETAILS ON THIS OVARIAN CANCER TRIAL
i2254/Ariel 4/CO-338-043 / NCT02855944 / Open 11-18-16 /